AAAAAA
Results:
1-7
|
Results: 7
Authors:
Aghi, M
Hochberg, F
Breakefield, XO
Citation: M. Aghi et al., Prodrug activation enzymes in cancer gene therapy, J GENE MED, 2(3), 2000, pp. 148-164
Authors:
Herrlinger, U
Jacobs, A
Aghi, M
Schuback, DE
Breakefield, XO
Citation: U. Herrlinger et al., HSV-1 vectors for gene therapy of experimental CNS tumors, METH MOL M, 35, 2000, pp. 287-312
Authors:
Aghi, M
Chou, TC
Breakefield, XO
Chiocca, EA
Citation: M. Aghi et al., Synergistic anticancer effects of ganciclovir thymidine kinase and 5-fluorocytosine cytosine deaminase gene therapies - Response, J NAT CANC, 91(3), 1999, pp. 285-286
Authors:
Aghi, M
Kramm, CM
Breakfield, XO
Citation: M. Aghi et al., Re: Folylpolyglutamyl synthetase gene transfer and glioma antifolate sensitivity in culture and in vivo - Response, J NAT CANC, 91(23), 1999, pp. 2048-2049
Authors:
Aghi, M
Kramm, CM
Breakefield, XO
Citation: M. Aghi et al., Folylpolyglutamyl synthetase gene transfer and glioma antifolate sensitivity in culture and in vivo, J NAT CANC, 91(14), 1999, pp. 1233-1241
Authors:
Pechan, PA
Herrlinger, U
Aghi, M
Jacobs, A
Breakefield, XO
Citation: Pa. Pechan et al., Combined HSV-1 recombinant and amplicon piggyback vectors: Replication-competent and defective forms, and therapeutic efficacy for experimental gliomas, J GENE MED, 1(3), 1999, pp. 176-185
Authors:
Aghi, M
Chou, TC
Suling, K
Breakefield, XO
Chiocca, EA
Citation: M. Aghi et al., Multimodal cancer treatment mediated by a replicating oncolytic virus thatdelivers the oxazaphosphorine/rat cytochrome P4502B1 and ganciclovir/herpes simplex virus thymidine kinase gene therapies, CANCER RES, 59(16), 1999, pp. 3861-3865
Risultati:
1-7
|